Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lucier

Former Life Technologies CEO Greg Lucier was named chairman and interim CEO of NuVasive following the resignation of Alex Lukianov. An internal investigation by the company's board found that Lukianov did not comply with NuVasive's expense reimbursement and other policies. 

Lucier has been a board member of NuVasive since 2013. From 2003 to 2014 he was chairman and CEO of Life Techn before it was acquired by Thermo Fisher Scientific. Prior to Life Tech, he was a corporate officer at General Electric and an executive at GE Medical Systems.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.